Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-07

Clinical Trial Update: A Study Comparing the Effect and Safety of Linaprazan Glurate to Lansoprazole in Maintenance of Healing in Participants With Healed Erosive Esophagitis (EE) Due to Gastroesophageal Reflux Disease (GERD) [Phase 3]

View source ↗

Summary

A Phase 3 study compares Linaprazan Glurate with Lansoprazole for maintenance of healing in healed erosive esophagitis due to gastroesophageal reflux disease; t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lansoprazole (Lansoprazole)
  • Linaprazan Glurate (linaprazan)

Snippet

Sponsor: Cinclus Pharma Holding AB | Conditions: GERD (Gastroesophageal Reflux Disease) | Phase 3 | Status: NOT_YET_RECRUITING